Table 1.A.
All Participants (N=71) |
Group 1a (n = 19) |
Group 2b (n = 16) |
Group 3c (n = 9) |
Group 4d (n = 27) |
P value | |
---|---|---|---|---|---|---|
Age, years (Mean±SD) | 55.56 ± 11.13 | 55.21 ± 10.75 | 55.50 ± 12.51 | 56.33 ± 11.41 | 55.59 ± 11.09 | .996 |
Male, N (%) | 47 (66.2%) | 13 (68.4%) | 10 (62.5%) | 6 (66.7%) | 18 (66.7%) | .986 |
Race, N (%) | .298 | |||||
Hispanic | 10 (14.1%) | 5 (26.3%) | 2 (12.5%) | 1 (11.1%) | 2 (7.4%) | |
White | 47 (66.2%) | 11 (57.9%) | 9 (56.3%) | 8 (88.9%) | 19 (70.4%) | |
African America | 14 (19.7%) | 3 (15.8%) | 5 (31.3% | 0 (0%) | 6 (22.2%) | |
Married, N (%) | 43 (60.6%) | 10 (52.6%) | 9 (56.3%) | 8 (88.9%) | 16 (59.3%) | .300 |
Employed, N (%) | 20 (28.3%) | 7 (36.8%) | 3 (18.8%) | 2 (22.2%) | 8 (29.6%) | .661 |
Education, N (%) | .086 | |||||
< 12 | 26 (26.6%) | 2 (7.7%) | 7 (26.9%) | 3 (11.5%) | 14 (53.8%) | |
12-16 | 29 (40.8%) | 10 (34.5%) | 7 (24.1%) | 5 (17.2%) | 7 (24.1%) | |
> 16 | 16 (22.1%) | 7 (43.8%) | 2 (12.5%) | 9 (12.7%) | 6 (37.5%) |
Group 1: participants with improvements in peak VO2 greater that 10%
Group 2: participants with improvements in peak VO2 less than 10%
Group 3: participants with reductions in peak VO2 less than 10%
Group 4: participants with reductions in peak VO2 greater that 10%